Alzheimer's disease (AD) is the most common form of neurodegenerative disorder with
dementia, accounting for approximately 70% of the all cases. Currently, 5.8 million people in …

Glycogen synthase kinase (GSK)-3 has been proposed as the link between the two
histopathological hallmarks of Alzheimer's disease, the extracellular senile plaques …

Glycogen synthase kinase-3 (GSK-3) is a ubiquitously expressed serine/threonine kinase
with a plethora of substrates. As a modulator of several cellular processes, GSK-3 has a …

Alzheimer's disease (AD) is a common neurodegenerative disorder that presents clinically
as inexorable cognitive impairment and decline in performance of activities of daily living …

Alzheimer disease (AD) is the most common form of age-related dementia. The etiology of
AD is considered to be multifactorial as only a negligible percentage of cases have a familial …

J. Neurochem.(2008) 104, 1433–1439. Abstract Glycogen synthase kinase 3 (GSK3) is a
constitutively active, proline‐directed serine/threonine kinase that plays a part in a number of …

Glycogen synthase kinase-3β (GSK3β) is a kinase that plays a pivotal role in numerous
cellular functions from modulation of microtubule dynamics and cell death. It also affects …

Originally discovered because of its role in the regulation of glucose metabolism, Glycogen
Synthase Kinase-3 (GSK-3) is now recognised as a crucial player in a diverse series of …

Glycogen synthase kinase-3 (GSK-3) is ubiquitously expressed and unusually active in
resting, non-stimulated cells. In mammals, at least three proteins (α, β1, and β2), generated …

Neurodegenerative diseases (NDDs) pose an increasingly prevalent threat to the well-being
and survival of elderly individuals worldwide. NDDs include Alzheimer's disease (AD) …